Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

442
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
442
Hypertension I: Introduction01:28

Hypertension I: Introduction

668
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
668
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

704
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
704
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

575
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
575
Pre-Procedural Guidelines for Assessing Blood Pressure01:10

Pre-Procedural Guidelines for Assessing Blood Pressure

790
Accurate blood pressure assessment is crucial for diagnosing and managing various health conditions. To ensure the reliability of these measurements, healthcare professionals must adhere to standardized pre-procedural guidelines. These guidelines enhance patient safety and improve the overall quality of healthcare. The following steps are essential for obtaining accurate and consistent blood pressure readings, from using the appropriate tools to ensuring effective communication with the...
790

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes: Insights Into Heart Failure Risk and Muscle Biology.

Journal of the American College of Cardiology·2026
Same author

Barriers to cardiovascular magnetic resonance across Europe: a 46-country EACVI observatory study.

European heart journal. Imaging methods and practice·2026
Same author

Left Atrioventricular Coupling Index in Health and Disease: A Longitudinal Multicohort Analysis.

Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance·2026
Same author

British Heart Foundation Data Science Centre 2.0: faster, fairer cardiovascular data-driven discovery.

European heart journal·2026
Same author

Measurement of quality of stroke care with national electronic health records: a prospective cohort study during and after the COVID-19 pandemic.

BMJ open·2026
Same author

European Society of Cardiology: cardiovascular disease statistics 2025.

European heart journal·2026

相关实验视频

Updated: Jan 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K

高血压的临床表现:以数据为导向的风险分层方法.

Elisa Rauseo1,2,3, Ahmed M Salih1,3,4,5, Jackie Cooper1

  • 1William Harvey Research Institute, NIHR Barts Biomedical Research Centre, Queen Mary University London, Charterhouse Square, United Kingdom. (E.R., A.M.S., J.C., M.A., S.C., H.N., P.B.M., N.A., S.E.P.).

Hypertension (Dallas, Tex. : 1979)
|December 11, 2025
PubMed
概括
此摘要是机器生成的。

无监督机器学习发现了三个不同的高血压表型. 一个男性占主导地位的集群显示高动脉样硬化和最大的心血管风险,而另一个类似于代谢综合征,风险中等.

关键词:
动脉样硬化 动脉样硬化心房动是心房动的一种.心脏衰竭是因为心脏衰竭.磁共振成像技术的使用现象型 现象型 是一种现象型.

更多相关视频

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.6K
Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model
07:10

Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model

Published on: June 3, 2020

10.5K

相关实验视频

Last Updated: Jan 9, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K
Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension
09:40

Hemodynamic Characterization of Rodent Models of Pulmonary Arterial Hypertension

Published on: April 11, 2016

21.6K
Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model
07:10

Induction and Characterization of Pulmonary Hypertension in Mice using the Hypoxia/SU5416 Model

Published on: June 3, 2020

10.5K

科学领域:

  • 心脏病学 心脏病学
  • 医疗信息学 医疗信息学
  • 遗传学 遗传学 是一个

背景情况:

  • 高血压是心血管疾病的主要原因,但其多样性使风险评估复杂化.
  • 无监督机器学习提供了一种方法来识别不同的患者子组,以便更好地分层风险和有针对性的预防.
  • 这项研究旨在使用数据驱动的方法来定义高血压表型及其与心血管结果的联系.

研究的目的:

  • 使用无监督机器学习识别高血压的不同临床现象.
  • 研究这些表型与心血管成像特征和不良临床结果的关联.
  • 评估心脏成像特征在高血压表型和结果之间的关系中的调解作用.

主要方法:

  • 对14840名被诊断为高血压和心血管磁共振成像数据的英国生物库参与者的分析.
  • 对77个临床变量应用k-means集群,以识别不同的高血压集群.
  • 检查集群和结果 (心力衰竭,心房动,动脉样事件,死亡率) 之间的关联,并根据风险因素进行调整,并对成像特征进行调解分析.

主要成果:

  • 确定了三个不同的高血压集群.
  • 集群2,主要是患有高动脉样硬化症的男性,表现出与严重心脏改造和功能障碍相关的所有不良心血管事件的最高风险.
  • 类似于代谢综合征的集群3显示出心房动和死亡的中度风险,风险部分介于左心室缩和左心房功能障碍.

结论:

  • 集群分析成功地确定了具有独特风险概况的独特高血压表型.
  • 这些发现表明,数据驱动的方法可以改善高血压风险分层.
  • 根据这些已识别的表型,可以制定定制的治疗策略.